Primary objective: To assess the impact of a low glycaemic load (GL) diet as compared to a *Western* diet on metabolic flexibility (the change in RQ) upon a hyperinsulinemic euglycemic clamp. Secondary objectives: 1) To assess the impact of low GL…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Metabolism
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- Delta RQ (change in the mean RQ value) before (fasted state) and at the end
of the 2.5-hour clamp period.
Secondary outcome
Secondary study parameters:
- Delta RQ (change in the mean RQ value) upon a mixed meal challenge
- Phenotypic flexibility markers, clustered into markers for
energy/carbohydrate metabolism, protein metabolism, lipid metabolism,
inflammation and vascular function, upon a mixed meal challenge
- Comparison of diet-induced changes in the kinetic response to diet-induced
changes in the baseline value
- Phenotypic flexibility markers, clustered into markers for
energy/carbohydrate metabolism, protein metabolism, lipid metabolism,
inflammation and vascular function, in the fasted state
- Insulin sensitivity
Other study parameters:
- Functional markers of cognitive and physical performance
- Sleep quality, mood and quality of life
- Body composition, 36-hour blood pressure, and 36-hour glycaemic response
Background summary
In general nutrition research aims at optimizing health and preventing
diseases. However, the effects of dietary interventions are in general subtle,
and few relevant biomarkers are available to show that nutrition has an effect
on health or risk factors for diseases. The WHO has defined health in the year
1946 as: *a state of complete physical, mental and social well-being and not
merely the absence of disease or infirmity. More recently a new definition has
been proposed for health and wellbeing, defining health as: *the ability to
cope with daily challenges*. This adaptive capacity is also called *phenotypic
flexibility* (PF). The concept is based on the hypothesis that the dynamic
responses of key physiological processes are more indicative of health and
wellbeing states than the more common baseline measurements of biomarkers. The
principle of PF is particularly established in the area of metabolic
flexibility, which, in a strict sense, is defined as the capability to switch
between fat and glucose oxidation after a meal. The gold standard for measuring
this defined metabolic flexibility is the change in respiratory quotient (RQ)
upon a hyperinsulinemic euglycemic clamp, although RQ can also be measured upon
a mixed meal. It has been shown that metabolic flexibility plays a role in
multiple health areas such as metabolic syndrome, diabetes, cardiovascular
health, weight management, oxidative stress and inflammation. It is affected by
lifestyle such as exercise, stress, sleep, and it is known to be altered in
compromised diseased population (e.g. overweight subjects) and can be modulated
by food ingredients, diets or caloric restriction.
Study objective
Primary objective: To assess the impact of a low glycaemic load (GL) diet as
compared to a *Western* diet on metabolic flexibility (the change in RQ) upon a
hyperinsulinemic euglycemic clamp.
Secondary objectives: 1) To assess the impact of low GL diet as compared to a
*Western* diet on metabolic flexibility (the change in RQ) upon a mixed meal
challenge, 2) to assess the impact of a low GL diet as compared to a *Western*
diet on the kinetic response of multiple PF markers during a mixed meal
challenge, 3) To assess the kinetic response of PF markers during a mixed meal
challenge over baseline measurements (fasted state), 4) to assess the impact of
a low GL diet as compared to a *Western* diet on these PF markers in the fasted
state, and 5) to assess the impact of a low GL diet as compared to a *Western*
diet on insulin sensitivity.
Study design
In the current study, the effectiveness of a dietary intervention will be
studied by means of measuring the change in RQ upon a hyperinsulinemic
euglycemic clamp challenge and by means of measuring the kinetic responses of
multiple PF markers (including RQ) to an acute mixed meal challenge before and
after a 6-week dietary intervention. The challenges will be applied to
investigate whether the kinetic response is a better measure for health and
wellbeing when compared to fasting (baseline) levels. In addition, several
measures that reflect perceivable benefits like mood, quality of life, sleep
quality, cognitive and physical performance will be assessed in a first
exploratory attempt to link (changes in) PF to consumer perceivable benefits.
Intervention
Subjects will first be subjected to a 2-week run-in diet consisting of products
that fit into a typical *Western* diet. Thereafter subjects will be randomly
allocated to a low glycemic load diet or a *Western* diet for 6 weeks. Before
and after the intervention several measurements will take place. The low
glycemic load diet will be high in polyphenols, protein, vegetables, pulses,
fibres and nuts, and low in glycemic carbohydrates. All these dietary factors
have been shown to improve glycemic control and/or to reduce metabolic syndrome
risk factors.
Study burden and risks
Results of this study will provide insight into whether the kinetic response is
a better measure for health and wellbeing when compared to fasting levels. No
direct health benefit for the participants is expected. However, there are some
burden and risks associated with the study; large time investment (13 visits
and ca. 38 hours spent at the test facility), being committed to a specific
diet for 2+6 weeks and wearing several devices at home, which will affect
subjects daily life and finally undergoing several test at the test facility
with minor risks, such as blood sampling, which can cause a local hematoma or
bruise.
Universiteitssingel 50
Maastricht 6200
NL
Universiteitssingel 50
Maastricht 6200
NL
Listed location countries
Age
Inclusion criteria
- Signed informed consent
- Men and postmenopausal women: >= 50 and <= 70 years at the start of the study
- Body mass index (BMI) >= 25.0 and <= 35.0 kg/m2
- Healthy (as determined by dependent physician): no medical conditions which might affect the study measurements, absorption, metabolism and distribution (including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases) as assessed by physical characteristics and health and lifestyle questionnaire
- Fasting blood glucose value <= 6.9 mmol/litre at screening
- Waist circumference >94 cm for males, >80 cm for females
- Maximum 2.5 hours of moderate to vigorous physical activity per week (during last 3 months)
- Agreeing to be informed about medically relevant personal test-results by a physician
- Willing to comply to study protocol during study
- Accessible veins on arms as determined by examination at screening
Exclusion criteria
- Reported participation in another nutritional or biomedical trial three months before the pre- study examination or during the study
- Blood donation in the past three months
- Reported participation in night shift work two weeks prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM
- Consumption of > 21 alcoholic units for males, > 14 alcohol units for females in a typical week
- Reported use of any nicotine containing products in the six months preceding the study and during the study itself
- Reported dietary habits: medically prescribed diet, slimming diet, vegetarian
- People who are familiar with an allergy or intolerance to any of the provided food products
- Reported weight loss or weight gain (10%) in the last six months prior to the pre-study screening
- Clinically relevant abnormalities in clinical chemistry at screening (to be judged by the study physician)
- Being an employee of Unilever or the collaborating research departments in Maastricht University Medical Centre (MUMC+)
- Taking medication, which may interfere with study measurements, as judged by the responsible physician
- Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL52245.068.15 |
Other | will be registered at clinicaltrials.gov |